Molecular Genetic Studies of the MMAA and MMAB
Genes in Chinese Methylmalonic Acidemia
Methylmalonic scidemia (MMA)
is an autosomal recessive disease of organic acid metabolism caused by defects
in mitochondrial methylmalonyl-CoA mutase (MCM, EC
5.4.99.2) or the synthesis deficiency of adenosylcobalamin
that acts as a cofactor for MCM. Generally speaking, MMA patients often fall
ill in infant stage and accumulate a lot of methylmalonate
in blood and urine during acute illness. MMA is classified into mut and cbl type according to different
complementation groups. Futhermore, mut type MMA can be classified into two sub-type, mut- or mut0, caused by partial or complete enzyme
deficiency, respectively. Cbl type MMA caused by the
synthesis deficiency of adenosylcobalamin can be
classified into six complement groups, namely cblA, cblB, cblC, cblD,
cblF, and cblH. Among which
cblA, cblB and cblH are isolated MMA while cblC,
cblD and cblF are combined
MMA and homocystinuria.
Twelve patients with elevated urinary methylmalonate were included in this study and classified
by clinical symptoms and biochemical findings for the MCM activity,
accumulation of methylmalonate in urine and
homocysteine in blood. One of these MMA patients was mut
type and the others were cbl types. Two of these cbl type MMA patients were
differentiated as isolated cbl
type MMA; seven were combined methylmalonic aciduria
and homocystinuria and two were unable to classify. In
this study, both the MMAA and MMAB genes were scanned to identify the genetic
mutation for four unrelated Chinese cbl type MMA patients
without homocystinuria. DNA sequence analysis of the
5'-UTR, 3'-UTR, coding region and the flanking regions of exons for the MMAA
gene had identified twleve single nucleotide polymorphisms
(SNPs) in the Chinese population.
Among which five SPS, termed c.-2233A/C, C.-1755A/G,
c.-1391A/T, c-996C/T and c.1089G/C had been reported elsewhere while the others
were novel SNPs, namely c.-1740 A/G, c.-713A/G, c.-469A/G, c.67+52C/T,
c.734-264G/A, c.819+168C/G and c.884+2678C/T. For the MMAB gene, we had
identified four published SNPs, 56-57GC/AA, c.520-96C/T, c.585-204A/G and
c.716T/A, and three novel SNPs, namely c.-414C/T,
c.520-159C/T and c.520-128C/T. The SNP identified in the Chinese population for
the MMAA and MMAB genes were in H-W equilibrium except c.-2263a/C (allele
frequency not determined) and c.-469A/G for MMAA and c.585-204A/G (allele
frequency not determined) for the MMAB. These SNPs in MMAA and MMAB genes may
assist in studying promoter, RNA stability and mRNA splicing mechanism of these
genes.
Mutation analysis of the MMAA gene for four unrelated
Chinese cbl type MMA patients without homocystinuria had identified a c.742C>T nd a c.-504C>T substitution. A homozygote of c.742C>T
mutation (Q248X), which had been reported as a disease-causing mutation, was
identified in the patient MMA001 from a consanguineous family. In the patient
MMA021, we had found a c.-504C>T alteration in the predicted promoter region
of the MMAA gene. RT-PCR combined sequencing analysis of the MMAA pre-mRNA for
MMA021 had shown 40% decreased expression of the c.-504T allele as compare to
the c.-504C allele. This data suggested the c.-504C>T mutation might affect
MMAA expression and leads to the disease.
MRNA analysis of the MMAB gene for MMA010 patient had
found to have some extent of intron 6 retention (r.519_520ins519+91_519+177)
while the mRNA of the MMAA gene expressed normally. This retention of intron 6 affects the
original reading frame of the protein leading to pre-mature translation stop
and produces a truncated protein with seventy-seven amino acids deleted at its
C-terminus. However, this intron 6 retention was also found in normal
lymphoblast cells suggesting alternative splicing in lymphoblast cells. None of
the variation other than
SNP in both the MMAA and MMAB genes (including the
predicted promoter regions) was found in patient MMA011. RT-PCR analysis of the
MMAA pre-mRNA suggested on of the MMAA allele did not expressed in this
patient. The genetic mutation of MMA011 patient remains to be addressed
further.